Technical Analysis for EDSA - Edesa Biotech, Inc.

Grade Last Price % Change Price Change
F 4.9492 -0.62% -0.03
EDSA closed down 9.29 percent on Thursday, March 4, 2021, on 29 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical EDSA trend table...

Date Alert Name Type % Chg
New Downtrend Bearish -0.80%
Lower Bollinger Band Walk Weakness -0.80%
Wide Bands Range Expansion -0.80%
Below Lower BB Weakness -0.80%
Down 3 Days in a Row Weakness -0.80%
Lower Bollinger Band Touch Weakness -0.80%
Oversold Stochastic Weakness -0.80%
MACD Bearish Centerline Cross Bearish -10.02%
Lower Bollinger Band Walk Weakness -10.02%
Wide Bands Range Expansion -10.02%
Older End-of-Day Signals for EDSA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 4 minutes ago
Down 10% about 3 hours ago
60 Minute Opening Range Breakdown about 4 hours ago
Down 5% about 4 hours ago
Rose Above Lower Bollinger Band about 5 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on efficiently developing innovative treatments that address significant unmet medical needs. Edesa's lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis which has demonstrated statistically significant improvements in multiple clinical studies. Edesa also intends to expand the utility of its sPLA2 inhibitor technology, which forms the basis for EB01, across multiple indications. The company is based in Toronto, Canada, with U.S. offices in Southern California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Industry Medication Dermatitis

Is EDSA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.1
52 Week Low 1.58
Average Volume 777,923
200-Day Moving Average 5.90
50-Day Moving Average 5.73
20-Day Moving Average 6.53
10-Day Moving Average 6.03
Average True Range 0.63
ADX 35.3
+DI 28.76
-DI 30.81
Chandelier Exit (Long, 3 ATRs ) 6.31
Chandelier Exit (Short, 3 ATRs ) 6.80
Upper Bollinger Band 7.94
Lower Bollinger Band 5.12
Percent B (%b) -0.05
BandWidth 43.19
MACD Line -0.14
MACD Signal Line 0.11
MACD Histogram -0.2534
Fundamentals Value
Market Cap 47.85 Million
Num Shares 9.61 Million
EPS -5.79
Price-to-Earnings (P/E) Ratio -0.86
Price-to-Sales 157.51
Price-to-Book 9.53
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.87
Resistance 3 (R3) 5.94 5.71 5.72
Resistance 2 (R2) 5.71 5.49 5.68 5.67
Resistance 1 (R1) 5.35 5.35 5.24 5.28 5.62
Pivot Point 5.12 5.12 5.07 5.09 5.12
Support 1 (S1) 4.76 4.90 4.65 4.69 4.34
Support 2 (S2) 4.53 4.76 4.50 4.29
Support 3 (S3) 4.17 4.53 4.24
Support 4 (S4) 4.10